Allarity Therapeutics Inc...

NASDAQ: ALLR · Real-Time Price · USD
0.87
-0.04 (-3.88%)
At close: Aug 20, 2025, 3:58 PM
0.89
2.42%
After-hours: Aug 20, 2025, 06:51 PM EDT

Allarity Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-24.52M -11.9M -16.06M -26.65M
Depreciation & Amortization
9K 37K 60K 106K
Stock-Based Compensation
71K -71K 1.75M 6.37M
Other Working Capital
4.13M 1.19M -6.54M 6.88M
Other Non-Cash Items
7.47M -4.26M -631K -466K
Deferred Income Tax
-446K 97K -1.61M 20K
Change in Working Capital
63K 3.35M -328K 5.57M
Operating Cash Flow
-17.35M -12.74M -16.82M -15.05M
Capital Expenditures
-298K n/a -18K n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a 809K 1M
Investing Cash Flow
-298K n/a 791K 1M
Debt Repayment
n/a -2.65M 1M 969K
Common Stock Repurchased
-3.5M -6.65M -1.51M n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 2.24M -800K 725K
Financial Cash Flow
36.79M 10.99M -1.31M 33.82M
Net Cash Flow
19.37M -1.86M -17.53M 19.26M
Free Cash Flow
-17.65M -12.74M -16.84M -15.05M